A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma

Clinical trial NCT05442554 · COMPLETED

Trial details

NCT number: NCT05442554
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

T-Cell Lymphoma

Start date: 2022-11-28
Primary completion: 2024-08-09
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.